Andrew J. Colebatch

2.2k total citations
34 papers, 792 citations indexed

About

Andrew J. Colebatch is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Andrew J. Colebatch has authored 34 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Andrew J. Colebatch's work include Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (11 papers) and Melanoma and MAPK Pathways (10 papers). Andrew J. Colebatch is often cited by papers focused on Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (11 papers) and Melanoma and MAPK Pathways (10 papers). Andrew J. Colebatch collaborates with scholars based in Australia, Netherlands and Denmark. Andrew J. Colebatch's co-authors include Richard A. Scolyer, Wendy A. Cooper, Alexander Dobrovic, Peter M. Ferguson, Ruta Gupta, Elizabeth C. Paver, Trina Lum, Sandra A. O’Toole, Lyndal Anderson and Joo‐Shik Shin and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Andrew J. Colebatch

32 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Colebatch Australia 15 516 272 173 126 91 34 792
Barbara Mino United States 18 620 1.2× 458 1.7× 217 1.3× 225 1.8× 254 2.8× 27 1.1k
Courtney W. Hudgens United States 16 544 1.1× 215 0.8× 269 1.6× 136 1.1× 116 1.3× 30 877
Shannon Carskadon United States 20 342 0.7× 402 1.5× 173 1.0× 196 1.6× 350 3.8× 35 919
Elizabeth Ruth Plummer United Kingdom 19 961 1.9× 836 3.1× 137 0.8× 181 1.4× 116 1.3× 69 1.3k
Sunandana Chandra United States 16 817 1.6× 424 1.6× 334 1.9× 122 1.0× 206 2.3× 49 1.2k
Dai Ogata Japan 16 393 0.8× 194 0.7× 124 0.7× 52 0.4× 72 0.8× 72 621
Tomonori Higuchi Japan 13 205 0.4× 250 0.9× 134 0.8× 52 0.4× 39 0.4× 27 560
Christoph Lahtz United States 11 244 0.5× 385 1.4× 102 0.6× 123 1.0× 41 0.5× 11 619
Gino K. In United States 13 372 0.7× 241 0.9× 95 0.5× 48 0.4× 129 1.4× 65 611
Nirasha Ramchurren United States 12 245 0.5× 192 0.7× 112 0.6× 75 0.6× 47 0.5× 19 526

Countries citing papers authored by Andrew J. Colebatch

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Colebatch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Colebatch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Colebatch more than expected).

Fields of papers citing papers by Andrew J. Colebatch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Colebatch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Colebatch. The network helps show where Andrew J. Colebatch may publish in the future.

Co-authorship network of co-authors of Andrew J. Colebatch

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Colebatch. A scholar is included among the top collaborators of Andrew J. Colebatch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Colebatch. Andrew J. Colebatch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reijers, Irene L. M., Petros Dimitriadis, Alexander M. Menzies, et al.. (2023). 1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma. Annals of Oncology. 34. S660–S660. 2 indexed citations
2.
Nguyen, Minh Anh, et al.. (2023). NTRK fusions in solid tumours: what every pathologist needs to know. Pathology. 55(5). 596–609. 10 indexed citations
3.
Pennington, Thomas E., Cathy Zhao, Andrew J. Colebatch, et al.. (2022). Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. Australasian Journal of Dermatology. 63(2). e133–e137. 1 indexed citations
4.
Attrill, Grace H., C. Owen, Tasnia Ahmed, et al.. (2022). Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy. Journal for ImmunoTherapy of Cancer. 10(6). e004771–e004771. 31 indexed citations
5.
Scolyer, Richard A., et al.. (2022). Biology and genetics of acquired and congenital melanocytic naevi. Pathology. 55(2). 169–177. 4 indexed citations
6.
Colebatch, Andrew J., Elizabeth C. Paver, Ismael A. Vergara, et al.. (2022). Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma. Pathology. 54(5). 533–540. 5 indexed citations
7.
Potter, Alison J., Andrew J. Colebatch, Robert V. Rawson, et al.. (2022). Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre. Pathology. 54(5). 526–532. 1 indexed citations
8.
Reijers, Irene L. M., Robert V. Rawson, Andrew J. Colebatch, et al.. (2022). Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma. JAMA Surgery. 157(4). 335–335. 25 indexed citations
9.
Satgunaseelan, Laveniya, Andrew J. Colebatch, Annabelle Mahar, et al.. (2021). ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology. 54(4). 399–403. 6 indexed citations
10.
Edwards, Jarem, Peter M. Ferguson, Serigne Lo, et al.. (2020). Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas. Cancer Immunology Research. 8(11). 1346–1353. 14 indexed citations
11.
Rytlewski, Julie, James S. Wilmott, Martín C. Mihm, et al.. (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature Cancer. 1(2). 197–209. 19 indexed citations
12.
Paver, Elizabeth C., Wendy A. Cooper, Andrew J. Colebatch, et al.. (2020). Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Pathology. 53(2). 141–156. 170 indexed citations
13.
Zhang, Xiaomeng, Jian Tang, Ismael A. Vergara, et al.. (2019). Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma. Molecular Cancer Research. 17(7). 1435–1449. 29 indexed citations
14.
Colebatch, Andrew J., Peter M. Ferguson, Felicity Newell, et al.. (2019). Molecular Genomic Profiling of Melanocytic Nevi. Journal of Investigative Dermatology. 139(8). 1762–1768. 42 indexed citations
15.
Halse, Heloise M., Andrew J. Colebatch, Pasquale Petrone, et al.. (2018). Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma. Scientific Reports. 8(1). 11158–11158. 74 indexed citations
16.
Colebatch, Andrew J. & Richard A. Scolyer. (2017). Trajectories of premalignancy during the journey from melanocyte to melanoma. Pathology. 50(1). 16–23. 22 indexed citations
17.
Colebatch, Andrew J., Leon Di Stefano, Stephen Q. Wong, et al.. (2016). Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. Oncotarget. 7(41). 66569–66585. 18 indexed citations
18.
Wilmott, James S., Andrew J. Colebatch, Hojabr Kakavand, et al.. (2015). Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma. Modern Pathology. 28(7). 884–894. 34 indexed citations
19.
Chan, David, et al.. (2011). A Very Unusual Presentation of Metastatic Colon Cancer. ISRN Oncology. 2011. 1–3. 1 indexed citations
20.
Paik, Julie, Geoffrey Hall, Adele Clarkson, et al.. (2011). Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Human Pathology. 42(10). 1385–1390. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Mino Breakdown of academic impact, for papers by Courtney W. Hudgens Breakdown of academic impact, for papers by Shannon Carskadon Breakdown of academic impact, for papers by Elizabeth Ruth Plummer Breakdown of academic impact, for papers by Sunandana Chandra Breakdown of academic impact, for papers by Dai Ogata Breakdown of academic impact, for papers by Tomonori Higuchi Breakdown of academic impact, for papers by Christoph Lahtz Breakdown of academic impact, for papers by Gino K. In Breakdown of academic impact, for papers by Nirasha Ramchurren
Rankless by CCL
2026